IRRITABLE BOWEL SYNDROME: PATHOGENETIC APPROACH TO THE TREATMENT OF ABDOMINAL PAIN
- Authors: Butorova L.I.1, Kalinin A.V.1, Butorova LI1, Kalinin AV1
-
Affiliations:
- Issue: No 12 (2011)
- Pages: 106-111
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278951
- ID: 278951
Cite item
Full Text
Abstract
The article considers the basic mechanisms of pain in irritable bowel syndrome (IBS), discusses the role of spasmolytics in the treatment of IBS. The results of a clinical study on the efficacy of monotherapy with calcium channel blocker pinaverium bromide (Dicetel) in patients with IBS and abdominal pain are presented.
References
- Ардатская М.Д. Синдром раздраженного кишечника. Клиническая лекция // Consilium medicum 2010. № 8. С. 48-54.
- Маев И.В., Самсонов А.А. и др. Синдром раздраженного кишечника, актуальность проблемы и вопросы современной терапии // Фарматека, 2011. № 2(214). С. 18-24.
- Яковенко Э.П., Агафонова Н.А., Яковенко А.В. и др. Роль моторных нарушений в механизмах формирования клинических проявлений синдрома раздраженного кишечника (СРК и СРК- подобных нарушений. Вопросы терапии // Consilium medicum, 2011. № 1. С. 69-73.
- Connel AM. Physiological and clinical assessment of the effect of the musculotropic agent mebeverin on the human colon. Br Med J 1965;2:848-51.
- Christen MO. Pinaverium bromide: A calcium antagonist with selectivity for the gastrointestinal tract. Today's Therapeutic Trends 1995;13(2):47-62.
- Drossman DA. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterol 2006;130(5).
- Dunlop SP, Jenkins D, Spiller RS. Distinctive clinical, psychological and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98(7):1578-83.
- Minderhould IM, Oldenburg B, Wismejer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationship with quality of life and coping behavior. Dig Dis Sci 2004;49:469-74.
- Morel N, Buryi V, Feron O, et al. The action of calcium channel blockers on recombinant L-type calcium channel a1-subunits. Br J Pharmacol 1998;125:1005-12.
- Poynard T, Naveau S, Mory B, et al. Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:355-61.
- Thompson WG, Irvine J, Pare P, et al. Functional gastrointestinal disorders in Canada: first population-based survey using Rome II criteria with suggestions for improving the questionnaire. Dig Dis Sci 2002;47:225-35.
Supplementary files
